Atrium Health Levine Children's Hospital — Charlotte, North Carolina

Atrium Health Levine Children's Hospital is a clinical research site located in Charlotte, North Carolina, United States 28203.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Atrium Health Levine Children's Hospital has participated in 11 clinical trials with 8 currently active.

Therapeutic areas: Cystic Fibrosis, Focal Segmental Glomerulosclerosis, Minimal Change Disease.

Sponsors: Vertex Pharmaceuticals Incorporated, Travere Therapeutics, Inc., University of Michigan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atrium Health Levine Children's Hospital?

Atrium Health Levine Children's Hospital has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atrium Health Levine Children's Hospital conducted?

Atrium Health Levine Children's Hospital has 11 clinical trials on record, with 8 currently active. Their work covers Cystic Fibrosis, Focal Segmental Glomerulosclerosis, Minimal Change Disease.

Is Atrium Health Levine Children's Hospital accredited by Crixeo Clinical Trials?

Atrium Health Levine Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atrium Health Levine Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.